Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis.

Banerji A, Busse P, Shennak M, Lumry W, Davis-Lorton M, Wedner HJ, Jacobs J, Baker J, Bernstein JA, Lockey R, Li HH, Craig T, Cicardi M, Riedl M, Al-Ghazawi A, Soo C, Iarrobino R, Sexton DJ, TenHoor C, Kenniston JA, Faucette R, Still JG, Kushner H, Mensah R, Stevens C, Biedenkapp JC, Chyung Y, Adelman B.

N Engl J Med. 2017 Feb 23;376(8):717-728. doi: 10.1056/NEJMoa1605767.

2.

Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance.

Bulitta JB, Okusanya OO, Forrest A, Bhavnani SM, Clark K, Still JG, Fernandes P, Ambrose PG.

Antimicrob Agents Chemother. 2013 Jan;57(1):498-507. doi: 10.1128/AAC.01354-12. Epub 2012 Nov 12.

3.

Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.

Rodvold KA, Gotfried MH, Still JG, Clark K, Fernandes P.

Antimicrob Agents Chemother. 2012 Oct;56(10):5076-81. doi: 10.1128/AAC.00766-12. Epub 2012 Jul 16.

4.

A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.

Craft JC, Moriarty SR, Clark K, Scott D, Degenhardt TP, Still JG, Corey GR, Das A, Fernandes P.

Clin Infect Dis. 2011 Jun;52 Suppl 7:S520-6. doi: 10.1093/cid/cir167.

PMID:
21546629
5.

Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.

Still JG, Clark K, Degenhardt TP, Scott D, Fernandes P, Gutierrez MJ.

Clin Infect Dis. 2011 Jun;52 Suppl 7:S504-12. doi: 10.1093/cid/cir174.

PMID:
21546627
6.

Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.

Still JG, Schranz J, Degenhardt TP, Scott D, Fernandes P, Gutierrez MJ, Clark K.

Antimicrob Agents Chemother. 2011 May;55(5):1997-2003. doi: 10.1128/AAC.01429-10. Epub 2011 Jan 31.

7.

Simulated first-phase insulin release using Humulin or insulin analog HIM2 is associated with prolonged improvement in postprandial glycemia.

DiCostanzo CA, Moore MC, Lautz M, Scott M, Farmer B, Everett CA, Still JG, Higgins A, Cherrington AD.

Am J Physiol Endocrinol Metab. 2005 Jul;289(1):E46-52. Epub 2005 Feb 15.

8.

Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium.

Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS.

Blood. 2005 Feb 1;105(3):1310-8. Epub 2004 Oct 7.

9.

Pharmacokinetics of modified oral calcitonin product in healthy volunteers.

Chin CM, Gutierrez M, Still JG, Kosutic G.

Pharmacotherapy. 2004 Aug;24(8):994-1001.

PMID:
15338848
10.

Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial.

Clement S, Dandona P, Still JG, Kosutic G.

Metabolism. 2004 Jan;53(1):54-8.

PMID:
14681842
11.

Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

Diabetes Care. 2003 Feb;26(2):421-6.

PMID:
12547873
12.

Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.

Clement S, Still JG, Kosutic G, McAllister RG.

Diabetes Technol Ther. 2002;4(4):459-66.

PMID:
12396740
13.
14.

Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response.

Gruber WC, Darden PM, Still JG, Lohr J, Reed G, Wright PF.

Vaccine. 1997 Aug-Sep;15(12-13):1379-84.

PMID:
9302748
15.

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial.

Astiz ME, Rackow EC, Still JG, Howell ST, Cato A, Von Eschen KB, Ulrich JT, Rudbach JA, McMahon G, Vargas R, et al.

Crit Care Med. 1995 Jan;23(1):9-17.

PMID:
8001393
16.

Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies.

Still JG, Hubbard WC, Poole JM, Sheaffer CI, Chartrand S, Jacobs R.

Pediatr Infect Dis J. 1993 Dec;12(12 Suppl 3):S134-41.

PMID:
8295815
17.
18.

Pulmonary artery sling: a new diagnostic tool and clinical review.

Rheuban KS, Ayres N, Still JG, Alford B.

Pediatrics. 1982 Apr;69(4):472-5.

PMID:
7070894
19.
20.

Differential reactivity of the gravid uterine vasculatures: effects of norepinephrine.

Anderson SG, Still JG, Greiss FC Jr.

Am J Obstet Gynecol. 1977 Oct 1;129(3):293-8.

PMID:
900198
21.

Uterine blood flow and its distribution after chronic estrogen and progesterone administration.

Anderson SG, Hackshaw BT, Still JG, Greiss FC Jr.

Am J Obstet Gynecol. 1977 Jan 15;127(2):138-42.

PMID:
831495
22.

Uterine pressure-flow relationships during early gestation.

Greiss FC Jr, Anderson SG, Still JG.

Am J Obstet Gynecol. 1976 Dec 1;126(7):799-808.

PMID:
998674
23.

Effects of local anesthetic agents on the uterine vasculatures and myometrium.

Greiss FC Jr, Still JG, Anderson SG.

Am J Obstet Gynecol. 1976 Apr 15;124(8):889-99.

PMID:
1258946
24.

Supplemental Content

Loading ...
Support Center